Duration of Hormone Replacement Therapy, Breast Tumour Size and Grade in a Screening Programme
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1024953926221
Reference29 articles.
1. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 350: 1047–1059, 1997
2. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Jama 288: 321–333, 2002
3. Kavanagh AM, Mitchell H, Giles GG: Hormone replacement therapy and accuracy of mammographic screening. Lancet 355: 270–274, 2000
4. Gajdos C, Tartter PI, Babinszki A: Breast cancer diagnosed during hormone replacement therapy. Obstet Gynecol 95: 513–518, 2000
5. Harding C, Knox WF, Faragher EB, Baildam A, Bundred NJ: Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit. Brit Med J 312: 1646–1647, 1996
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Histological transformation to signet-ring cell carcinoma in a patient with clinically aggressive poorly differentiated adenocarcinoma of the ascending colon after response to chemotherapy plus cetuximab: a case report;World Journal of Surgical Oncology;2023-06-07
2. Histological transformation to signet-ring cell carcinoma in a patient with clinically aggressive poorly differentiated adenocarcinoma of the ascending colon after response to chemotherapy plus cetuximab: a case report;2023-03-14
3. Estrogens;Meyler's Side Effects of Drugs;2016
4. Breast cancer after hormone replacement therapy – does prognosis differ in perimenopausal and postmenopausal women?;The Breast;2011-10
5. Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network;Breast Cancer Research and Treatment;2010-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3